Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 2008-2013

  Meyer, B ^a   Krisponeit, D ^b   Junghanss, C ^c   Escobar, H Murua ^d   Bullerdiek, J ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b KLINIKUM BREMEN MITTE   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Chronic myeloid leukaemia; High mobility group protein A2; Quantitative real time RT PCR

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; LEUKEMIA CELL; LEUKOCYTE COUNT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; UPREGULATION;

ADULT; AGED; BLAST CRISIS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HMGA2 PROTEIN; HUMANS; LEUKEMIA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTE COUNT; MIDDLE AGED; MODELS, STATISTICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UP-REGULATION;

EID: 35148883399     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701559116     Document Type: Article

References (36)

1. Reeves, R. and Nissen, M. S. (1990) The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem, 265, pp. 8573-8582.
2. Bustin, M. and Reeves, R. (1996) High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol, 54, pp. 35-100.
3. Schoenmakers, E. F., Wanschura, S., Mols, R., Bullerdiek, J., Berghe, H Van den and Van de Ven, W. J. (1995) Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet, 10, pp. 436-444.
4. Hennig, Y., Rogalla, P., Wanschura, S., Frey, G., Deichert, U. and Bartnitzke, S. (1997) HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. Cancer Genet Cytogenet, 96, pp. 129-133.
5. Gattas, G. J., Quade, B. J., Nowak, R. A. and Morton, C. C. (1999) HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer, 25, pp. 316-322.
6. Ashar, H. R., Fejzo, M. S., Tkachenko, A., Zhou, X., Fletcher, J. A. and Weremowicz, S. (1995) Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell, 82, pp. 57-65.
7. Rogalla, P., Drechsler, K., Frey, G., Hennig, Y., Helmke, B. and Bonk, U. (1996) HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol, 149, pp. 775-779.
8. Hirning-Folz, U., Wilda, M., Rippe, V., Bullerdiek, J. and Hameister, H. (1998) The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer, 23, pp. 350-357.
9. Zhou, X., Benson, K. F., Ashar, H. R. and Chada, K. (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature, 376, pp. 771-774.
10. Battista, S., Fidanza, V., Fedele, M., Klein-Szanto, A. J., Outwater, E. and Brunner, H. (1999) The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res, 59, pp. 4793-4797.
11. Ligon, A. H., Moore, S. D., Parisi, M. A., Mealiffe, M. E., Harris, D. J. and Ferguson, H. L. (2005) Constitutional rearrangement of the architectural factor HMGA2: A novel human phenotype including overgrowth and lipomas. Am J Hum Genet, pp. 340-348.
12. Miyazawa, J., Mitoro, A., Kawashiri, S., Chada, K. K. and Imai, K. (2004) Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res, 64, pp. 2024-2029.
13. Rogalla, P., Drechsler, K., Kazmierczak, B., Rippe, V., Bonk, U. and Bullerdiek, J. (1997) Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog, 19, pp. 153-156.
14. Abe, N., Watanabe, T., Suzuki, Y., Matsumoto, N., Masaki, T. and Mori, T. (2003) An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer, 89, pp. 2104-2109.
15. Rogalla, P., Drechsler, K., Schroder-Babo, W., Eberhardt, K. and Bullerdiek, J. (1998) HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res, 18, pp. 3327-3330.
16. Meyer, B., Loeschke, S., Schultze, A., Weigel, T., Sandkamp, M. and Goldmann, T. (2007) HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog, 46, pp. 503-511.
17. Langelotz, C., Schmid, P., Jakob, C., Heider, U., Wernecke, K. D. and Possinger, K. (2003) Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer, 88, pp. 1406-1410.
18. Sezer, O., Langelotz, C., Blohmer, J. U., Schmid, P., Akrivakis, K. and Possinger, K. (2000) Detection of HMGI-C in the peripheral blood of breast cancer patients. Eur J Cancer, 36, pp. 1944-1948.
19. Fabjani, G., Tong, D., Wolf, A., Roka, S., Leodolter, S. and Hoecker, P. (2005) HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol Rep, 14, pp. 737-741.
20. Rommel, B., Rogalla, P., Jox, A., Kalle, C. V., Kazmierczak, B. and Wolf, J. (1997) HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma, 26, pp. 603-607.
21. Patel, H. S., Kantarjian, H. M., Bueso-Ramos, C. E., Medeiros, L. J. and Haidar, M. A. (2005) Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer, 42, pp. 87-94.
22. Santulli, B., Kazmierczak, B., Napolitano, R., Caliendo, I., Chiappetta, G. and Rippe, V. (2000) A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet, 119, pp. 70-73.
23. Pierantoni, G. M., Santulli, B., Caliendo, I., Pentimalli, F., Chiappetta, G. and Zanesi, N. (2003) HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol, 23, pp. 363-367.
24. Andrieux, J., Demory, J. L., Dupriez, B., Quief, S., Plantier, I. and Roumier, C. (2004) Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer, 39, pp. 82-87.
25. Odero, M. D., Grand, F. H., Iqbal, S., Ross, F., Roman, J. P. and Vizmanos, J. L. (2005) Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia, 19, pp. 245-252.
26. Kottickal, L. V., Sarada, B., Ashar, H., Chada, K. and Nagarajan, L. (1998) Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia. Biochem Biophys Res Commun, 242, pp. 452-456.
27. Inoue, N., Izui-Sarumaru, T., Murakami, Y., Endo, Y., Nishimura, J. I. and Kurokawa, K. (2006) Molecular basis of clonal expansion of hematopoiesis in two patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood, 108, pp. 4232-4236.
28. Guglielmelli, P., Zini, R., Bogani, C., Salati, S., Pancrazzi, A. and Bianchi, E. (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilm's tumor gene (WT1). Stem Cells, 25, pp. 165-173.
29. Hochhaus, A., Berger, U., Reiter, A., Engelich, G., Lahaye, T. and Kreil, S. (2002) [Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group]. Internist, 43, pp. 1228-1244.
30. Gross, K. L., Neskey, D. M., Manchanda, N., Weremowicz, S., Kleinman, M. S. and Nowak, R. A. (2003) HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer, 38, pp. 68-79.
31. Clarkson, B. D., Strife, A., Wisniewski, D., Lambek, C. and Carpino, N. (1997) New understanding of the pathogenesis of CML: A prototype of early neoplasia. Leukemia, 11, pp. 1404-1428.
32. Hehlmann, R., Berger, U. and Hochhaus, A. (2005) Chronic myeloid leukemia: A model for oncology. Ann Hematol, 84, pp. 487-497.
33. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiere, P. and Cary, P. (1991) cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res, 19, pp. 6793-6797.
34. Zhou, X., Benson, K. F., Przybysz, K., Liu, J., Hou, Y. and Cherath, L. (1996) Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res, 24, pp. 4071-4077.
35. Boo, L. M., Lin, H. H., Chung, V., Zhou, B., Louie, S. G. and O'Reilly, M. A. (2005) High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res, 65, pp. 6622-6630.
36. Borrmann, L., Schwanbeck, R., Heyduk, T., Seebeck, B., Rogalla, P. and Bullerdiek, J. (2003) High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res, 31, pp. 6841-6851.